12.20
-0.15(-1.21%)
Currency In USD
| Previous Close | 12.35 |
| Open | 12.23 |
| Day High | 12.75 |
| Day Low | 12.03 |
| 52-Week High | 13.48 |
| 52-Week Low | 1.03 |
| Volume | 1.64M |
| Average Volume | 2.96M |
| Market Cap | 1.35B |
| PE | -13.41 |
| EPS | -0.91 |
| Moving Average 50 Days | 10.65 |
| Moving Average 200 Days | 7.32 |
| Change | -0.15 |
If you invested $1000 in Tango Therapeutics, Inc. (TNGX) since IPO date, it would be worth $1,192.57 as of February 21, 2026 at a share price of $12.2. Whereas If you bought $1000 worth of Tango Therapeutics, Inc. (TNGX) shares 5 years ago, it would be worth $932.01 as of February 21, 2026 at a share price of $12.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences
GlobeNewswire Inc.
Feb 18, 2026 12:00 PM GMT
BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report fourth quarter 2025 financial results on March 5, 2026, before the open of the U.S. financial markets. The company does not inten
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
GlobeNewswire Inc.
Feb 03, 2026 12:00 PM GMT
BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the Guggenhei
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
GlobeNewswire Inc.
Jan 08, 2026 2:05 PM GMT
Founding CEO Barbara Weber, M.D. to become executive chair of the board of directorsMalte Peters, M.D., current board member, appointed President and Chief Executive Officer, effective immediately – BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Tango T